Abstract
We report on a case of adriamycin cardiotoxicity occurring in a five-year-old boy treated for rhabdomyosarcoma. In addition to the usual features of myofibrillary degeneration associated with adriamycin, extreme endocardial fibrosis and mural thrombosis affecting the apical segments of both ventricles but particularly the left ventricle was seen at necropsy. The changes resembled classical endomyocardial fibrosis.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adriamycin-induced myocardial lesions. Report of a workshop. Am J Surg Pathol. 1977 Mar;1(1):55–60. doi: 10.1097/00000478-197701010-00006. [DOI] [PubMed] [Google Scholar]
- Bonadonna G., Monfardini S., De Lena M., Fossati-Bellani F., Beretta G. Phase I and preliminary phase II evaluation of adriamycin (NSC 123127). Cancer Res. 1970 Oct;30(10):2572–2582. [PubMed] [Google Scholar]
- Connor D. H., Somers K., Hutt M. S., Manion W. C., D'Arbela P. G. Endomyocardial fibrosis in Uganda (Davies' disease). 1. An epidemiologic, clinical, and pathologic study. Am Heart J. 1967 Nov;74(5):687–709. doi: 10.1016/0002-8703(67)90509-1. [DOI] [PubMed] [Google Scholar]
- Connor D. H., Somers K., Hutt M. S., Manion W. C., D'Arbela P. G. Endomyocardial fibrosis in Uganda (Davies' disease). II. An epidemiologic, clinical, and pathologic study. Am Heart J. 1968 Jan;75(1):107–124. doi: 10.1016/0002-8703(68)90122-1. [DOI] [PubMed] [Google Scholar]
- DAVIES J. N., BALL J. D. The pathology of endomyocardial fibrosis in Uganda. Br Heart J. 1955 Jul;17(3):337–359. doi: 10.1136/hrt.17.3.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lefrak E. A., Pitha J., Rosenheim S., Gottlieb J. A. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer. 1973 Aug;32(2):302–314. doi: 10.1002/1097-0142(197308)32:2<302::aid-cncr2820320205>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
- Lenaz L., Page J. A. Cardiotoxicity of adriamycin and related anthracyclines. Cancer Treat Rev. 1976 Sep;3(3):111–120. doi: 10.1016/s0305-7372(76)80018-7. [DOI] [PubMed] [Google Scholar]
- Middleman E., Luce J., Frei E., 3rd Clinical trials with adriamycin. Cancer. 1971 Oct;28(4):844–850. doi: 10.1002/1097-0142(1971)28:4<844::aid-cncr2820280407>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
- Wang J. J., Cortes E., Sinks L. F., Holland J. F. Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease. Cancer. 1971 Oct;28(4):837–843. doi: 10.1002/1097-0142(1971)28:4<837::aid-cncr2820280406>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
- Wilcox R. G., James P. D., Toghill P. J. Endomyocardial fibrosis associated with daunorubicin therapy. Br Heart J. 1976 Aug;38(8):860–863. doi: 10.1136/hrt.38.8.860. [DOI] [PMC free article] [PubMed] [Google Scholar]